Literature DB >> 3366410

Variability in caffeine consumption from coffee and tea: possible significance for epidemiological studies.

B Stavric1, R Klassen, B Watkinson, K Karpinski, R Stapley, P Fried.   

Abstract

Five surveys, using a previously developed high-performance liquid chromatography procedure to measure caffeine concentrations, indicated great variations in the concentrations of caffeine in tea and coffee. In the study of beverages prepared at home, data on caffeine concentrations in 58 samples of tea and coffee, volumes of cups, and numbers of cups consumed/day, indicated that the range of caffeine intakes for the women participating was 49-1022 mg/day. There were considerable day-to-day variations in caffeine contents in coffee samples from some commercial coffee shops. When 17 samples of five national brands of instant coffee were made into beverages in the laboratory, variations in caffeine concentrations between lots were small but between brands were significant. A considerable range of caffeine concentrations was also found when 12 samples of coffee prepared at work by different individuals using the same jar of instant coffee were analysed. Analysis of tea samples prepared in the laboratory indicated that steeping time had an important influence on resulting caffeine and theobromine concentrations. People preparing their own beverages were found to drink more liquid than the volume offered commerically. The mean caffeine 'contents' of home-made coffee and of coffee prepared by individuals at work were 79.4 and 81.7 mg/cup respectively, indicating a mean intake of approximately 80 mg caffeine/cup. When this amount (80 mg/cup) was used to estimate daily intakes of caffeine from coffee, on the basis of the number of reported cups/day, and the values obtained were compared with the amounts actually consumed by individuals, the potential for misrepresentation of individual consumption became obvious. For example, for subjects consuming three cups of coffee, only 25% would have been correctly categorized in the expected range for the daily intake of caffeine, 39% would have been overestimated and 36% underestimated for the amount of caffeine consumed. These variations in caffeine concentrations and in the volume of coffee consumed have frequently been ignored in examinations of the possible relationship between coffee consumption and various health problems, and this could perhaps partly explain some conflicting results seen in epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366410     DOI: 10.1016/0278-6915(88)90107-x

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease.

Authors:  Patricia K Sonsalla; Lai-Yoong Wong; Suzan L Harris; Jason R Richardson; Ida Khobahy; Wenhao Li; Bharathi S Gadad; Dwight C German
Journal:  Exp Neurol       Date:  2012-01-28       Impact factor: 5.330

2.  Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition.

Authors:  Saverio Caini; Giovanna Masala; Calogero Saieva; Marina Kvaskoff; Isabelle Savoye; Carlotta Sacerdote; Oskar Hemmingsson; Bodil Hammer Bech; Kim Overvad; Anne Tjønneland; Kristina E N Petersen; Francesca Romana Mancini; Marie-Christine Boutron-Ruault; Iris Cervenka; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Anna Floegel; Antonia Trichopoulou; Elisavet Valanou; Maria Kritikou; Giovanna Tagliabue; Salvatore Panico; Rosario Tumino; H B As Bueno-de-Mesquita; Petra H Peeters; Marit B Veierød; Reza Ghiasvand; Marko Lukic; José Ramón Quirós; Maria-Dolores Chirlaque; Eva Ardanaz; Elena Salamanca Fernández; Nerea Larrañaga; Raul Zamora-Ros; Lena Maria Nilsson; Ingrid Ljuslinder; Karin Jirström; Emily Sonestedt; Timothy J Key; Nick Wareham; Kay-Tee Khaw; Marc Gunter; Inge Huybrechts; Neil Murphy; Konstantinos K Tsilidis; Elisabete Weiderpass; Domenico Palli
Journal:  Int J Cancer       Date:  2017-03-09       Impact factor: 7.396

3.  Self-report reliability and symptomatology of habitual caffeine consumption.

Authors:  J E James; M S Bruce; M H Lader; N R Scott
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

4.  Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects.

Authors:  J Sato; H Nakata; E Owada; T Kikuta; M Umetsu; K Ito
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Prospective Cohort Study of Caffeinated Beverage Intake as a Potential Trigger of Headaches among Migraineurs.

Authors:  Elizabeth Mostofsky; Murray A Mittleman; Catherine Buettner; Wenyuan Li; Suzanne M Bertisch
Journal:  Am J Med       Date:  2019-08-08       Impact factor: 4.965

6.  Nutrition and Rheumatoid Arthritis Onset: A Prospective Analysis Using the UK Biobank.

Authors:  Camilla Barbero Mazzucca; Lorenza Scotti; Giuseppe Cappellano; Francesco Barone-Adesi; Annalisa Chiocchetti
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

7.  Maternal caffeine consumption and risk of neural tube defects.

Authors:  Rebecca J Schmidt; Paul A Romitti; Trudy L Burns; Marilyn L Browne; Charlotte M Druschel; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.